Cargando…

Standard Dose Ivermectin for COVID-19

Detalles Bibliográficos
Autores principales:	Buonfrate, Dora, Bisoffi, Zeno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Chest Physicians. Published by Elsevier Inc. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097313/ https://www.ncbi.nlm.nih.gov/pubmed/33965138 http://dx.doi.org/10.1016/j.chest.2021.03.003

Ejemplares similares

Efficacy of High-Dose Albendazole with Ivermectin for Treating Imported Loiasis, Italy
por: Gobbi, Federico, et al.
Publicado: (2019)

Progress towards the implementation of control programmes for strongyloidiasis in endemic areas: estimation of number of adults in need of ivermectin for strongyloidiasis
por: Buonfrate, Dora, et al.
Publicado: (2024)

Randomized Clinical Trial on Ivermectin versus Thiabendazole for the Treatment of Strongyloidiasis
por: Bisoffi, Zeno, et al.
Publicado: (2011)

Preventive chemotherapy for the control of strongyloidiasis in school-age children: Estimating the ivermectin need
por: Bisanzio, Donal, et al.
Publicado: (2021)

High-dose ivermectin for early treatment of COVID-19 (COVER study): a randomised, double-blind, multicentre, phase II, dose-finding, proof-of-concept clinical trial
por: Buonfrate, Dora, et al.
Publicado: (2022)

Ivermectin in COVID-19. Argumentun ad ignorantiam?()
por: Carlosama-Rosero, Y.
Publicado: (2020)

Travel, infections, and the importance of networking in the global health perspectives
por: Buonfrate, Dora, et al.
Publicado: (2020)

Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador
por: Anselmi, Mariella, et al.
Publicado: (2015)

Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?()
por: López Reboiro, M.L., et al.
Publicado: (2020)

Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
por: Camprubí, Daniel, et al.
Publicado: (2020)

Control programs for strongyloidiasis in areas of high endemicity: an economic analysis of different approaches
por: Buonfrate, Dora, et al.
Publicado: (2021)

Diagnosis of Malaria Infection with or without Disease
por: Bisoffi, Zeno, et al.
Publicado: (2012)

The hyper-reactive malarial splenomegaly: a systematic review of the literature
por: Leoni, Stefania, et al.
Publicado: (2015)

Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19
por: Temple, Courtney, et al.
Publicado: (2021)

Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19
por: Chuang, Tzu-Yi, et al.
Publicado: (2021)

Correction: Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients
por: Camprubí, Daniel, et al.
Publicado: (2022)

Failure of malaria chemoprophylaxis with mefloquine in an oversize traveller to Mozambique
por: Gobbi, Federico, et al.
Publicado: (2013)

Systemic profile of immune factors in an elderly Italian population affected by chronic strongyloidiasis
por: Tiberti, Natalia, et al.
Publicado: (2020)

Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine
por: Gobbi, Federico, et al.
Publicado: (2021)

The Laboratory Diagnosis and Follow Up of Strongyloidiasis: A Systematic Review
por: Requena-Méndez, Ana, et al.
Publicado: (2013)

Use of a “tablet pole” for the administration of ivermectin for strongyloidiasis in a field study in Ecuador
por: Buonfrate, Dora, et al.
Publicado: (2023)

Blastocystis prevalence and subtypes in autochthonous and immigrant patients in a referral centre for parasitic infections in Italy
por: Piubelli, Chiara, et al.
Publicado: (2019)

Ultrasound and intestinal lesions in Schistosoma mansoni infection: A case-control pilot study outside endemic areas
por: Tamarozzi, Francesca, et al.
Publicado: (2018)

Response to Letter Regarding Article, “Effects of Ivermectin in Patients With COVID-19: A Multicenter, Double-Blind, Randomized, Controlled Clinical Trial”
por: Shahbaznejad, Leila, et al.
Publicado: (2021)

The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19
por: Schmith, Virginia D., et al.
Publicado: (2020)

Prevalence of Strongyloidiasis in a Cohort of Migrants in Italy and Accuracy of a Novel ELISA Assay for S. stercoralis Infection, a Cross-Sectional Study
por: Buonfrate, Dora, et al.
Publicado: (2021)

Autochthonous Cases of Mycetoma in Europe: Report of Two Cases and Review of Literature
por: Buonfrate, Dora, et al.
Publicado: (2014)

Failure of dihydroartemisinin-piperaquine treatment of uncomplicated Plasmodium falciparum malaria in a traveller coming from Ethiopia
por: Gobbi, Federico, et al.
Publicado: (2016)

Diagnostic study on an immunochromatographic rapid test for schistosomiasis: comparison between use on serum and on blood spot from fingerprick
por: Buonfrate, Dora, et al.
Publicado: (2018)

Acute histoplasmosis in immunocompetent travelers: a systematic review of literature
por: Staffolani, Silvia, et al.
Publicado: (2018)

Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol
por: Salvador, Fernando, et al.
Publicado: (2021)

Standards and Stereotypes in COVID-19
por: Epelbaum, Oleg
Publicado: (2020)

Diagnostic accuracy of a novel enzyme-linked immunoassay for the detection of IgG and IgG4 against Strongyloides stercoralis based on the recombinant antigens NIE/SsIR
por: Tamarozzi, Francesca, et al.
Publicado: (2021)

Should Malaria Treatment Be Guided by a Point of Care Rapid Test? A Threshold Approach to Malaria Management in Rural Burkina Faso
por: Bisoffi, Zeno, et al.
Publicado: (2013)

Severe strongyloidiasis: a systematic review of case reports
por: Buonfrate, Dora, et al.
Publicado: (2013)

Extended screening for infectious diseases among newly-arrived asylum seekers from Africa and Asia, Verona province, Italy, April 2014 to June 2015
por: Buonfrate, Dora, et al.
Publicado: (2018)

Schistosomiasis in immigrants, refugees and travellers in an Italian referral centre for tropical diseases
por: Marchese, Valentina, et al.
Publicado: (2018)

Ivermectin Should Not Be Recommended to Treat Severe Acute Respiratory Syndrome 2 Infection
por: Boven, A G, et al.
Publicado: (2021)

Ivermectin for Coronavirus Disease 2019: Yet to Be Well Evaluated Before Clinical Use
por: Hagiya, Hideharu, et al.
Publicado: (2021)

Sensitivity, Specificity and Predictive Values of Molecular and Serological Tests for COVID-19: A Longitudinal Study in Emergency Room
por: Bisoffi, Zeno, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ochvt7enmcc53s63bv9tqarld1